VIRBAC SA (VIRP.PA) Stock Price, Forecast & Analysis
Europe - EPA:VIRP - FR0000031577 - Common Stock
VIRP.PA Key Statistics, Chart & Performance
The current stock price of VIRP.PA is 345 EUR. In the past month the price increased by 11.29%. In the past year, price decreased by -2.13%.
VIRP.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.48 | 212.54B | ||
| SAN.PA | SANOFI | 11.24 | 208.13B | ||
| SNW.DE | SANOFI | 11.24 | 208.11B | ||
| 1MRK.MI | MERCK KGAA | 13.35 | 49.41B | ||
| MRK.DE | MERCK KGAA | 12.86 | 47.59B | ||
| UCB.BR | UCB SA | 35.31 | 44.10B | ||
| 1BAYN.MI | BAYER AG-REG | 5.28 | 26.00B | ||
| BAYN.DE | BAYER AG-REG | 5.2 | 25.60B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.24 | 10.40B | ||
| IPN.PA | IPSEN | 12.05 | 10.38B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 97.84 | 9.06B | ||
| DMP.DE | DERMAPHARM HOLDING SE | 16.58 | 1.78B |
Related stock screener links
About VIRP.PA
Company Profile
Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca and currently employs 5,620 full-time employees. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
Company Info
VIRBAC SA
13e rue LID - BP 27
Carros PACA FR
Employees: 6365
Phone: 33492087100
VIRBAC SA / VIRP.PA FAQ
What does VIRBAC SA do?
Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca and currently employs 5,620 full-time employees. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
Can you provide the latest stock price for VIRBAC SA?
The current stock price of VIRP.PA is 345 EUR. The price increased by 2.07% in the last trading session.
What is the dividend status of VIRBAC SA?
VIRBAC SA (VIRP.PA) has a dividend yield of 0.42%. The yearly dividend amount is currently 1.32.
What is the ChartMill technical and fundamental rating of VIRP stock?
VIRP.PA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What do analysts say about VIRBAC SA (VIRP.PA) stock?
15 analysts have analysed VIRP.PA and the average price target is 403.28 EUR. This implies a price increase of 16.89% is expected in the next year compared to the current price of 345.
Can you provide the market cap for VIRBAC SA?
VIRBAC SA (VIRP.PA) has a market capitalization of 2.89B EUR. This makes VIRP.PA a Mid Cap stock.
Can you provide the upcoming earnings date for VIRBAC SA?
VIRBAC SA (VIRP.PA) will report earnings on 2026-01-15, after the market close.
VIRP.PA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to VIRP.PA. When comparing the yearly performance of all stocks, VIRP.PA is a bad performer in the overall market: 62.54% of all stocks are doing better.
VIRP.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to VIRP.PA. VIRP.PA has an average financial health and profitability rating.
VIRP.PA Financial Highlights
Over the last trailing twelve months VIRP.PA reported a non-GAAP Earnings per Share(EPS) of 17.34. The EPS increased by 20.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.4% | ||
| ROA | 8% | ||
| ROE | 13.64% | ||
| Debt/Equity | 0.22 |
VIRP.PA Forecast & Estimates
15 analysts have analysed VIRP.PA and the average price target is 403.28 EUR. This implies a price increase of 16.89% is expected in the next year compared to the current price of 345.
For the next year, analysts expect an EPS growth of 3.93% and a revenue growth 4.62% for VIRP.PA